Stanbio Laboratory Release: New Web Portal Focuses on Testing for Diabetic Ketoacidosis With ß-Hydroxybutyrate  
2/21/2012 1:33:00 PM

BOERNE, TX, February 21, 2012 – Stanbio Laboratory has launched a new web portal focused on the benefits and importance of testing for diabetic ketoacidosis (DKA) – a potentially dangerous condition that can affect diabetics and others with metabolic imbalances. DKA can occur when there is not enough glucose (carbohydrates) to provide for the body's energy needs.

The Stanbio Laboratory web portal is a collection of information designed to help clinicians, physicians, diabetic nurse educators, medical sales professionals and patients better understand DKA, its risk factors, symptoms and also testing methods using ß-hydroxybutyrate. Stanbio Laboratory makes an enzymatic chemistry reagent, ß-hydroxybutyrate LiquiColor®, which is used on clinical chemistry analyzers to quantifiably measure the presence and degree of ketosis. This enzymatic testing method represents a significant improvement over the more common semi-quantitative methods of testing.

“Our new web portal will be a convenient place for medical professionals to find useful clinical information about DKA – while also learning about applications for our unique ß-hydroxybutyrate chemistry reagent,” said William R. Pippin, Stanbio Laboratory President. “We have seen increasing demand for our ß-hydroxybutyrate product by many of the top hospitals in the U.S. – and now, mid-size and small hospitals are asking for it too,” Pippin added.

James H. Nichols, Ph.D., DABCC, FACB, Medical Director, Clinical Chemistry for Tufts University School of Medicine, helped review the structure and content of the Stanbio ß-hydroxybutyrate web portal. “I think this web site will be a useful resource for anyone interested in testing for ketosis,” Nichols said.

A user name and password are required to view the portal. To get a user name and password, individuals can visit and select the Sign Up link at the top of the home page.

Founded in 1960 and headquartered in Boerne, Texas, Stanbio Laboratory manufactures and markets medical testing and diagnostic devices including clinical chemistry, pregnancy, strep A, serology, urinalysis, and point-of-care hemoglobin tests. Stanbio Laboratory’s Quality System is ISO 13485 registered and its facility operates under USFDA current GMP requirements. Stanbio also offers OEM and private labeling capabilities and distributes products in over 125 countries worldwide. This year the company celebrates its 52nd year in business. To find out more about Stanbio, review its news, or learn more about its products, visit

EKF Diagnostics Holdings plc is a worldwide manufacturer of near-patient care equipment for the measurement of glucose, lactate, hemoglobin, hematocrit and glycated hemoglobin (HbA1c). It offers its products to the professional clinical and research laboratories, doctors’ offices, sports clinics, and athletic testing sites. The company is headquartered in London, the United Kingdom.